P. Cryer, Hypoglycemia in diabètes, Diabetes Care, vol.52, pp.2083-2089, 2003.

B. Campaigne, H. Wallberg-henriksson, and R. Gunnarsson, Glucose and insuline responses in relation to insuline dose and caloric intake 12 h after acute physical exercise in men with IDDM, Diabetes Care, pp.10-716, 1987.

D. Vries, J. Snoek, F. Kostense, and P. , A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control, Diabetes Care, pp.25-2074, 2002.

R. Hoogma, P. Hammond, and R. Gomis, Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial, Diabetic Medicine, vol.22, issue.2, pp.141-147, 2006.
DOI : 10.1046/j.1464-5491.2002.00750.x

I. Hirsch, B. Bode, and S. Garg, Insulin aspart CSII/MDI Comparison Study Group, Diabetes Care, pp.28-533, 2005.

B. Bode, R. Steed, and P. Davidson, Reduction in sévère hypoglycemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes, Diabetes Care, pp.324-327, 1996.

?. Grimaldi, D. Traité-de-diabétologie, T. C. Raccah, A. Coste, P. Gerbi et al., Les supplémentations nutritionnelles en acides gras polyinsaturés dans le traitement de la neuropathie diabétique périphérique, Cahiers de Nutrition et de Diététique (58) A. Grimaldi ? Traité de Diabétologie 2 ème édition -Médecine-Sciences Flammarion, ) Fosse S., Jacqueminet SA, Duplan H et al., Incidence et caractéristiques des amputations de membres inférieurs chez les personnes diabétiques en France métropolitaine, pp.643-349, 2003.

L. Diabétologie and . Monnier, jpg (70) http://www.has-sante.fr/portail/upload/docs/application/pdf/2009- 03/autoanalyse_glycemie_2007.pdf (71) http://www.sfdiabete.org/sites/sfd.prod/files/files/ressources/sfd_paramed_surveillanc e_mars2012.pdf (72) A. Grimaldi, L'éducation thérapeutique du patient diabétique, ou apprendre à gérer l'incertitude, Médecine des maladies métaboliques, 75) L. Dufaitre-Pastouraux, P. Vague, V Lassmann-Vague, History, accuracy and précision of SMBG devices Diabetes Metab, pp.56-69, 2003.

W. Clarke, D. Cox, and L. Gonder-frederick, Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose, Diabetes Care, vol.10, issue.5, pp.10-622, 1987.
DOI : 10.2337/diacare.10.5.622

H. Thèse-de and . Jourdan, (79) L. Dufaitre-Pastouraux, P. Vague, V Lassmann-Vague, History, accuracy and précision of SMBG devices Diabetes Metab, Thèse de H. Jourdan, Amélioration du contrôle qualité des lecteurs de glycémie capillaire au CHU de Nantes, pp.24-46, 2003.

). L. Dufaitre-patouraux, K. Djemli, and P. Vague, How and when to use an alternative site in self-monitoring of blood glucose, Diabetes & Metabolism, vol.30, issue.5, pp.471-477, 2004.
DOI : 10.1016/S1262-3636(07)70145-3

Z. Bloomgarden, Randomized, controlled trial of diabetic patient éducation : improved knowledge without improved metabolic status, Diabetes Care, Mai-Juin, pp.263-272, 1987.

T. Korhonen, A controlled trial on the effects of patients éducation in the treatment of insulin-dependent diabètes, Diabetes Care, Mai-Juin, pp.256-261, 1983.

M. Debaty, P. Baudrant, S. Benhamou, and . Halimi, Evaluation de la qualité de vie en éducation thérapeutique du patient diabétique : intérêt et limites des échelles standardisées, Médecine des maladies métaboliques, pp.291-293, 2007.

S. Hennadil, J. Rennert, and B. Wenzel, Comparison of glucose concentration in (113) https://www.accu-chek-congresses.com/easd/ (114) https://www.animas.com/diabetes-insulin-pump-and-blood-glucose-meter/animas- vibe-insulin-pump (115) https://www.medtronic-diabetes.be/sites/belgium/medtronicdiabetes .be/files/uc200905129fb_b2c_16.pdf (116) http://www.euro-pharmat.com/documents/journees_lille/posters_lille/47posterlille.pdf (117) B. Guerci, Enregistrement de la glycémie en continu : quelles retombées ?, Maladies_chroniques/201208_ETP_EnfantsMaladiesChro niques.pdf (95)119) Kaufman FR, Gibson LC, Halvorson M et al., A pilot study of the continuous glucose monitoring system : clinical décisions and glycemic control after its use in pediatric type 1 diabetic subjects, pp.1559-1566, 2001.

A. Sola-gazagnes, La mesure du glucose en continu dans la « vraie vie, Diabète et obésité, mars 2012, pp.57-89

P. Benhamou, Société Francophone du Diabète; Société Française d'Endocrinologie; EVAluation dans le Diabète des Implants ACtifs Group. Real-time continuous glucose monitoring (CGM) integrated into the treatment of type 1 diabetes: consensus of experts from SFD, EVADIAC and SFE, Diabetes & Metab, issue.121122, 2012.

T. Battelino, I. Conget, B. Olsen, I. Schütz-fuhrmann, E. Hommel et al., The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial, Diabetologia, vol.35, issue.Suppl 1, pp.3155-3162, 2012.
DOI : 10.2337/dc11-2021

R. Bergenstal, D. Klono, S. Garg, B. Bode, M. Meredith et al., Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia, New England Journal of Medicine, vol.369, issue.3, pp.224-232, 2013.
DOI : 10.1056/NEJMoa1303576

R. Mcqueen, S. Ellis, and J. Campbell, Cost-effectiveness of continuous glucose monitoring and intensive insulin therapy for type 1 diabetes, Cost Effectiveness and Resource Allocation, vol.9, issue.1, pp.13-1269, 2010.
DOI : 10.2337/diacare.28.3.617

R. Bergenstal, W. Tamborlane, and A. Ahmann, Sensor-Augmented Pump Therapy for A1C Reduction (STAR 3) Study: Results from the 6-month continuation phase, Diabetes Care, vol.34, issue.11, pp.2403-2405, 2011.
DOI : 10.2337/dc11-1248

B. Catargi, E. Mghari, G. Sauvanet, and J. , Mesure en continu de la glycémie : Pourquoi ? Comment ? Pour quelles indications ? Médecine des maladies Métaboliques, pp.2-400, 2008.

T. Bailey, B. Bode, M. Christiansen, and L. Klaff, The performance and usability of a factory-calibrated flash glucose monitoring system http://diabete-infos.fr/etude-impact-systeme-freestyle-libre Insulin pump therapy : a meta-analysis, Diabetes Technology & Therapeutics Diabetes Care, vol.17, issue.145146148, pp.11-26, 2003.

B. Zinman, The physiologic replacement of insulin : An elusive goal, New England Journal of Medecine, pp.8-597, 1989.

E. Renard and P. Schaepelynck-belicar, Implantable insulin pumps. A position statement about their??clinical use, Diabetes & Metabolism, vol.33, issue.2, pp.158-166, 2007.
DOI : 10.1016/j.diabet.2006.10.004

URL : https://hal.archives-ouvertes.fr/hal-00171152

E. Renard, Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy, Current Opinion in Pharmacology, vol.2, issue.6, pp.708-716, 2002.
DOI : 10.1016/S1471-4892(02)00216-3

E. Renard, J. Place, M. Pelletier, and A. Farret, Insulinothérapie en boucle fermée : vers le pancréas artificiel ambulatoire, Médecine des maladies métaboliques, pp.6-490, 2012.

P. Choudhary, J. Shin, and Y. Wang, Insulin pump therapy with automated insulin suspension in response to hypoglycemia : reduction in nocturnal hypoglycemia in